Rosalind Advisors Group Affirms 9.9% Stake in Delcath Systems, Capped by Ownership Blockers

summarizeSummary

Rosalind Advisors and its affiliates, including two board members, updated their beneficial ownership in Delcath Systems, confirming a 9.9% stake subject to ownership blockers.

check_boxKey Events

• Significant Beneficial Ownership

  Rosalind Advisors, Inc. and its affiliated funds, along with Steven Salamon and Gil Aharon, collectively report beneficial ownership of 9.9% of Delcath Systems' common stock as of December 31, 2025.

• Ownership Blockers in Place

  The reported stake is subject to conversion and exercise blockers, limiting beneficial ownership to 9.99% for preferred stock and 4.99% for warrants, preventing full conversion/exercise of their holdings.

• Board Representation

  Steven Salamon and Gilad Aharon, associated with the Rosalind group, were elected as independent directors in May 2020, highlighting the group's ongoing influence.

auto_awesomeAnalysis

This Schedule 13D/A filing updates the beneficial ownership of Rosalind Advisors, Inc. and its affiliated funds, along with Steven Salamon and Gil Aharon, in Delcath Systems. The group collectively reports a 9.9% stake in the company as of December 31, 2025. This significant ownership is subject to conversion and exercise blockers, limiting their beneficial ownership to 9.99% for preferred stock and 4.99% for warrants. The filing also notes that Steven Salamon and Gilad Aharon, both associated with Rosalind Advisors, were elected as independent directors in May 2020, indicating an ongoing influential position within the company.